Shinya Yamamoto

10PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 10, 2024
Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy.

Ryo Fujiwara, Shinya Yamamoto, Kosuke Takemura

|Mar 13, 2024
Surgical outcomes and predictive value for major complications of robot-assisted radical cystectomy of real-world data in a single institution in Japan.

Yosuke Yasuda, Noboru Numao, Ryo Fujiwara

|Jan 04, 2024
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy.

Ichiro Yonese, Noboru Numao, Kentaro Inamura

|Jun 18, 2022
Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma.

Kosuke Hamada, Ryo Fujiwara, Kosuke Takemura

|Sep 09, 2021
The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma.

Kasumi Kaneko Yoshitomi, Noboru Numao, Yosuke Umino

|Jun 12, 2021
External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer.

Eri Fukagawa, Shinya Yamamoto, Sachiko Ohde

Pageof 2

Frequent Collaborators

6 joint publications

Takeshi Yuasa

5 joint publications

Ryo Fujiwara

2 joint publications

Kosuke Hamada

2 joint publications

Yoshinobu Komai